Brexit: Issues And Opportunities As UK Life Sciences Define A New Relationship In Europe
Executive Summary
It's fair to say that the outcome of the June 23, 2016 referendum on the UK’s membership of the EU stunned not only the nation, whether you voted to leave or remain, but sent shockwaves through Europe and beyond. The UK’s pharmaceutical industry made no secret of its stance: it was all about remain – but it got a Brexit instead. Scrip’s Sukaina Virji gathered a group of pharma industry experts who spent the summer working on making the best of the situation around a table and recorded their insightful discussion. Listen to the full conversation here.